Abstract
Enterovirus 71 (EV71) causes fatal encephalitis in young children. However, there is no effective antiviral drug available for infected patients. Ribavirin is currently used for the treatment of several RNA virus infections clinically, so its anti-EV71 efficacy was evaluated. In vitro results showed that ribavirin effectively reduced the viral yields (with an IC50 of 65 μg/mL) and virus-induced cytopathic effect in human and mouse cell lines. In vivo results showed that ribavirin reduced the mortality, morbidity, and subsequent paralysis sequelae in infected mice by decreasing viral loads in tissues. Thus, ribavirin could be a potential anti-EV71 drug.
Original language | English |
---|---|
Pages (from-to) | 854-857 |
Number of pages | 4 |
Journal | Journal of Infectious Diseases |
Volume | 197 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2008 Mar 15 |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Infectious Diseases